Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation

Blaine W. Robinson, Kathryn C. Behling, Manish Gupta, Alena Y. Zhang, Jonni S. Moore, Andrew D. Bantly, Cheryl L. Willman, Andrew J. Carroll, Peter C. Adamson, Jeffrey S. Barrett, Carolyn A. Felix

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation'. Together they form a unique fingerprint.

Medicine & Life Sciences